Looking for polycystic ovary syndrome genes: Rational and best strategy

Seminars in Reproductive Medicine

Volumn 26, Issue 1, 2008, Pages 5-13

  Goodarzi, Mark O ^a,b,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Medical Genetics Institute   (Israel)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d NONE   (United States)

Author keywords

Association; Candidate gene; Haplotype; Replication; Single nucleotide polymorphism

Indexed keywords

INSULIN;

ADRB2 GENE; AGT GENE; ARTICLE; CAPN5 GENE; CYP11B2 GENE; CYP19 GENE; CYP1A1 GENE; D19S884 GENE; DIAGNOSTIC PROCEDURE; EPHX GENE; FEM1A GENE; FEMALE; GENE; GENE EXPRESSION; GENOME ANALYSIS; GNAS GENE; GSK3B GENE; GSTM1 GENE; GSTT1 GENE; HAPLOTYPE; HLA A GENE; HLA B GENE; HLA DRB1 GENE; HSD17B6 GENE; HUMAN; HYPERANDROGENISM; IGF2 GENE; IL1A GENE; IL6 GENE; IL6R GENE; IL6ST GENE; INSULIN RELEASE; INSULIN RESISTANCE; IRS1 GENE; MMP1 GENE; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PATHOPHYSIOLOGY; PC1 GENE; PHENOTYPE; PON1 GENE; PPP1R3A GENE; PREVALENCE; SHBG GENE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SRD5A1 GENE; SRD5A2 GENE; STEROIDOGENESIS; SULT2A1 GENE; TNFR2 GENE;

FEMALE; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; INFERTILITY, FEMALE; LINKAGE DISEQUILIBRIUM; MODELS, BIOLOGICAL; POLYCYSTIC OVARY SYNDROME; REPRODUCTION;

EID: 38149138010     PISSN: 15268004     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-992919     Document Type: Article

References (40)

1. King RA, Rotter JI, Motulsky AG. The Genetic Basis of Common Diseases. 2nd ed. New York, NY: Oxford University Press; 2002
2. Goodarzi MO, Azziz R. Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome. Best Pract Res Clin Endocrinol Metab 2006;20:193-205
3. Parikh H, Groop L. Candidate genes for type 2 diabetes. Rev Endocr Metab Disord 2004;5:151-176
4. Pall M, Stephens K, Azziz R. Family size in women with polycystic ovary syndrome. Fertil Steril 2006;85:1837-1839
5. Nam Menke M, Strauss JF. Genetics of polycystic ovarian syndrome. Clin Obstet Gynecol 2007;50:188-204
6. Franks S, McCarthy M. Genetics of ovarian disorders: polycystic ovary syndrome. Rev Endocr Metab Disord 2004;5:69-76
7. Escobar-Morreale HF, Luque-Ramirez M, San Millan JL. The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocr Rev 2005;26:251-282
8. Diamanti-Kandarakis E, Piperi C. Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth. Hum Reprod Update 2005;11:631-643
9. Urbanek M. The genetics of the polycystic ovary syndrome. Nat Clin Pract Endocrinol Metab 2007;3:103-111
10. Unluturk U, Harmanci A, Kocaefe C, Yildiz BO. The genetic basis of the polycystic ovary syndrome: a literature review including discussion of PPAR-gamma. PPAR Res 2007:49109
11. Thomas DC, Witte JS. Point: population stratification: a problem for case-control studies of candidate-gene associations? Cancer Epidemiol Biomarkers Prev 2002;11:505-512
12. Wacholder S, Rothman N, Caporaso N. Counterpoint: bias from population stratification is not a major threat to the validity of conclusions from epidemiological studies of common polymorphisms and cancer. Cancer Epidemiol Biomarkers Prev 2002;11:513-520
13. Goodarzi MO, Shah NA, Antoine HJ, et al. Variants in the 5alpha-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women. J Clin Endocrinol Metab 2006;91:4085-4091
14. Carmina E, Legro RS, Stamets K, Lowell J, Lobo RA. Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet. Hum Reprod 2003;18:2289-2293
15. Beavis WD. QTL analyses: power, precision, and accuracy. In: Paterson AH, ed. Molecular Dissection of Complex Traits. New York, NY: CRC Press; 1998:145-162
16. Wild RA, Vesely S, Beebe L, Whitsett T, Owen W. Ferriman Gallwey self-scoring I: performance assessment in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:4112-4114
17. Zawadzki JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine F, Merriam GR, eds. Polycystic Ovary Syndrome. Cambridge, MA: Blackwell Scientific; 1992:377-384
18. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25
19. Urbanek M, Legro RS, Driscoll DA, et al. Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proc Natl Acad Sci U S A 1999;96:8573-8578
20. Urbanek M, Woodroffe A, Ewens KG, et al. Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2. J Clin Endocrinol Metab 2005;90:6623-6629
21. Stewart DR, Dombroski B, Urbanek M, et al. Fine mapping of genetic susceptibility to polycystic ovary syndrome on chromosome 19p13.2 and tests for regulatory activity. J Clin Endocrinol Metab 2006;91:4112-4117
22. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-2229
23. The International HapMap Consortium. The International HapMap Project. Nature 2003;426:789-796
24. Horikawa Y, Oda N, Cox NJ, et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 2000;26:163-175
25. Vollmert C, Hahn S, Lamina C, et al. Calpain-10 variants and haplotypes are associated with polycystic ovary syndrome in Caucasians. Am J Physiol Endocrinol Metab 2007;292:E836-E844
26. Gonzalez A, Saez ME, Aragon MJ, et al. Specific haplotypes of the CALPAIN-5 gene are associated with polycystic ovary syndrome. Hum Reprod 2006;21:943-951
27. Petry CJ, Ong KK, Michelmore KF, et al. Association of aromatase (CYP 19) gene variation with features of hyperandrogenism in two populations of young women. Hum Reprod 2005;20:1837-1843
28. Goodarzi MO, Antoine HJ, Pall M, et al. Preliminary evidence of glycogen synthase kinase 3 beta as a genetic determinant of polycystic ovary syndrome. Fertil Steril 2007;87:1473-1476
29. Goodarzi MO, Antoine HJ, Azziz R. Genes for enzymes regulating DHEA sulfonation are associated with levels of DHEA-sulfate in polycystic ovary syndrome. J Clin Endocrinol Metab 2007;92:2659-2664
30. Jones MR, Wilson SG, Mullin BH, et al. Polymorphism of the follistatin gene in polycystic ovary syndrome. Mol Hum Reprod 2007;13:237-241
31. Petry CJ, Ong KK, Wingate DL, et al. Lack of association between common polymorphisms in the 17beta-hydroxysteroid dehydrogenase type V gene (HSD17B5) and precocious pubarche. J Steroid Biochem Mol Biol 2007;105:176-180
32. Jones MR, Italiano L, Wilson SG, et al. Polymorphism in HSD17B6 is associated with key features of polycystic ovary syndrome. Fertil Steril 2006;86:1438-1446
33. Purcell S, Cherny SS, Sham PC. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003;19:149-150
34. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993;52:506-516
35. Hughes C, Elgasim M, Layfield R, Atiomo W. Genomic and post-genomic approaches to polycystic ovary syndrome - progress so far: mini review. Hum Reprod 2006;21:2766-2775
36. Ho CK, Wood JR, Stewart DR, et al. Increased transcription and increased messenger ribonucleic acid (mRNA) stability contribute to increased GATA6 mRNA abundance in polycystic ovary syndrome theca cells. J Clin Endocrinol Metab 2005;90:6596-6602
37. Saxena R, Voight BF, Lyssenko V, et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007;316:1331-1336
38. Scott LJ, Mohlke KL, Bonnycastle LL, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007;316:1341-1345
39. Sladek R, Rocheleau G, Rung J, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007;445:881-885
40. Zeggini E, Weedon MN, Lindgren CM, et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007;316:1336-1341